Difference between revisions of "Al Shahrani M"
From Bioblast
m (moved Al-Sharani M to Al-Shahrani M) |
Nirschl Lisa (talk | contribs) |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=Al | |lastname=Al Shahrani | ||
|firstname=Mesfer | |firstname=Mesfer | ||
|institution=The National Hospital for Neurology & Neurosurgery | |institution=The National Hospital for Neurology & Neurosurgery | ||
| Line 6: | Line 6: | ||
Neurometabolic Unit | Neurometabolic Unit | ||
|address=Queen Square | |address=Queen Square | ||
|area code=WC1N 3BG | |||
|city=London | |city=London | ||
|country=United Kingdom | |country=United Kingdom | ||
| Line 11: | Line 12: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | |||
::::*[[IOC101| IOC101 London UK]] | |||
::::* [[IOC100| IOC100 Schroecken AT]] | |||
Latest revision as of 10:49, 26 April 2018
| Name | Al Shahrani Mesfer, |
|---|---|
| Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
| Address | Queen Square, WC1N 3BG |
| City | London |
| State/Province | |
| Country | United Kingdom |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | UK London Land JM |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |
